about
HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanismsHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsSoluble factors from IL-1β-stimulated astrocytes activate NR1a/NR2B receptors: implications for HIV-1-induced neurodegeneration.Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.CXCL8 protects human neurons from amyloid-β-induced neurotoxicity: relevance to Alzheimer's disease.Regulation of tissue inhibitor of metalloproteinase-1 by astrocytes: links to HIV-1 dementia.Potential mechanisms for astrocyte-TIMP-1 downregulation in chronic inflammatory diseases.Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects.HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway.Isolation and HIV-1 infection of primary human microglia from fetal and adult tissue.CD38/cyclic ADP-ribose regulates astrocyte calcium signaling: implications for neuroinflammation and HIV-1-associated dementia.CD38 regulation in activated astrocytes: implications for neuroinflammation and HIV-1 brain infection.Role of activated astrocytes in neuronal damage: potential links to HIV-1-associated dementia.Development of a rapid autopsy program for studies of brain immunity.Blood-based inflammation biomarkers of neurocognitive impairment in people living with HIVInsights into the Gene Expression Profiles of Active and Restricted Red/Green-HIV+ Human Astrocytes: Implications for Shock or Lock Therapies in the BrainArginine-Modified Polymers Facilitate Poly (Lactide-Co-Glycolide)-Based Nanoparticle Gene Delivery to Primary Human Astrocytes
P50
Q24294630-F4C95978-FE92-452E-9532-D0D54341DA17Q28392199-B5DF7827-19A9-477E-A886-9EEC8545B358Q34311427-9A35A748-D66F-437A-9B88-959935B19C18Q34607184-F50BD207-6563-452F-8F9E-CEDCC3EDFEE4Q35038078-C4A02EB3-75F9-42F1-B995-AE899FAAC072Q35607995-DC04D816-32EB-417A-9EC4-3411E9DEA9D0Q37287856-83CE195E-866F-4A8C-BE08-416473DD236EQ40300764-EBC96F19-D450-42B1-862A-CAEB2F6383F5Q42477745-93B3623E-D83D-48C0-A2C8-8456D06B7B31Q44231742-4492EF84-E44C-4672-BF58-5BFFC7D1EA58Q44736128-3489E458-4AE8-43F2-9595-65C301E97831Q45765135-ACB1F95D-2B93-4852-8EAE-0EB5C1B30D4FQ46051624-5233E8CD-A198-4F20-9E13-C3A710527D08Q46493395-0A30382B-15D0-42BB-97A2-51C5C676062BQ48892186-54FC5988-685F-45C9-9F56-A1E72172D494Q90473861-8650D605-2E79-4104-9914-35AA9EA302AAQ92379480-B3C42A10-5AD1-4F03-9711-4D6960CEE0D2Q96432588-38D39A66-6BF3-4FBA-AAF4-DBFC9E9A2DE6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kathleen Borgmann
@ast
Kathleen Borgmann
@en
Kathleen Borgmann
@es
Kathleen Borgmann
@nl
Kathleen Borgmann
@sl
type
label
Kathleen Borgmann
@ast
Kathleen Borgmann
@en
Kathleen Borgmann
@es
Kathleen Borgmann
@nl
Kathleen Borgmann
@sl
prefLabel
Kathleen Borgmann
@ast
Kathleen Borgmann
@en
Kathleen Borgmann
@es
Kathleen Borgmann
@nl
Kathleen Borgmann
@sl
P106
P21
P2798
P31
P496
0000-0003-0897-390X